2022 Early Hearing Detection & Intervention Virtual Conference
March 13 - 15, 2022
3/09/2015 | 2:00 PM - 2:30 PM | Developing a Hospital CMV Testing Protocol without State Mandate | French | 1
Developing a Hospital CMV Testing Protocol without State Mandate
The effects of congenital CMV on infants are well documented but there is little uniformity on a national level regarding early identification of CMV, particularly in asymptomatic babies. Since hearing loss is the most common sequelae following a congenital CMV infection (AAP), several states have initiated mandated CMV testing for infants that do not pass their hearing screening, thus allowing for earlier diagnosis and management. However, most states have no mandate. Beth Israel Deaconess Medical Center (BIDMC) and Brigham and Women’s Hospital (BWH) in Boston have successfully developed and implemented their own hospital based CMV testing protocol to help identify babies with CMV. The speakers will discuss the strategies they used and ways other hospitals can move forward with setting up their own policy. The presentation will include supporting materials to bring to administration, procedures for testing including criteria, supplies, and family support materials, lab codes/cost of testing, tracking, and what to do when a baby comes up positive. Finally, a case study showing the process and diagnostic outcome from Boston Children’s Hospital will be reviewed.
- Determine likely areas of concern administration may have and be able to gather support material regarding why CMV testing is important to their hospital hearing program.
- Identify steps necessary and colleagues important to include in the development of a hospital CMV protocol.
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Jennifer Bentley
(Primary Presenter,POC), BIDMC, jbentle1@bidmc.harvard.edu;
Jennifer Bentley is the Coordinator for the Newborn Hearing Screening Program at Beth Israel Deaconess Medical Center, in Boston.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
Margaret Toro
(Co-Presenter), Brigham and Women's Hospital, mrtoro@partners.org;
Margaret Toro is the director/coordinator of newborn hearing screening at Brigham and Women's Hospital in Boston, MA. She has worked previously as coordinator of newborn hearing screening and pediatric audiologist at Boston Medical Center.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
Charlotte Mullen
(Co-Presenter), Boston Children's Hospital, charlotte.mullen@childrens.harvard.edu;
Charlotte Mullen, AuD, a Co-Presentor for this resource, is the primary pediatric audiologist for the Deaf and Hard of Hearing Program and Specialty Audiologist for Education and Training for the audiology service of Boston Children’s Hospital. She founded the Sound Outreach to Schools educational audiology program. Dr. Mullen has given numerous presentations to professional and parent groups. Her clinical work initially identified an increased incidence in hearing loss among children treated by extra-corporeal membrane oxygenation (ECMO). Working closely with the Developmental Medicine Program, Dr. Mullen developed a clinical practice guideline for audiological monitoring which led to incorporation into the 2007 Joint Committee on Infant Hearing recommendations. Dr. Mullen is a founding member of the Audiology Clinical Education Network. She also coordinates the Virtual Pediatric Audiology meetings which provides a large forum for learning and discussing issues pertaining to pediatric practice.
ASHA DISCLOSURE:
Financial -
Nonfinancial -